Retatrutide
GIP / GLP-1 / glucagon receptor tri-agonist. Investigational.
from $60.005 mg · 10 mg · 30 mg · 50 mg · 60 mg
5-Amino-1MQ
Quinolinium small molecule. NNMT inhibitor.
Vial size
Quantity
- Form
- Powder (small molecule)
- Molecular weight
- 173.2 g/mol (cation)
- CAS
- 42464-96-0
- Storage
- −20 °C, protected from light
- Documentation
- Certificate of analysis by lot
- Intended use
- In-vitro laboratory research
Research context
- NNMT inhibition
- NAD+ salvage pathway
- Adipocyte metabolism
Research use only. Not for human or veterinary use. Not approved by Health Canada and carries no DIN. Molecular weight and CAS are literature values for the base compound; the lot COA is the authoritative description of the material supplied.
Also in metabolic
Tirzepatide
GIP / GLP-1 receptor co-agonist. C20 fatty diacid moiety.
from $54.5010 mg · 15 mg · 20 mg · 30 mg · 60 mg
Semaglutide
GLP-1 receptor agonist. Aib8 substitution, C18 diacid side chain.
from $40.505 mg · 10 mg · 20 mg
Cagrilintide
Acylated long-acting amylin analogue. Amylin and calcitonin receptor activity.
from $47.505 mg · 10 mg